CeMM Level 8, Seminar Room
Benjamin Schuster-Böckler
Group Leader, Ludwig Institute for Cancer Research, Oxford, United Kingdom
"The influence of cell-intrinsic processes on mutation rate"
Host: Joanna Loizou
Biosketch:
Benjamin Schuster-Böckler received his undergraduate degree in bioinformatics from the Free University Berlin, before joining the Sanger Institute in Cambridge, UK, as PhD student. During his time at the Sanger, next-generation genome sequencing came of age, providing new opportunities to look at the biology of the genome. As a post-doc in Barcelona in 2011, Benjamin demonstrated that the packaging of DNA into chromatin influences the distribution of cancer mutations in the genome. Since starting his own lab in 2013, he has studied the effect of a wide range of cell-intrinsic processes on mutagenesis. Since 2018, Benjamin is an associate member of Ludwig Cancer Research and a member of the Big Data Institute in Oxford. His recent work has yielded novel insights in how DNA damage, epigenetic marks and DNA replication interact to cause mutations.
9:00am - 6:00pm, CeMM Lecture Hall, 8th floor
For the sixth time, the Vienna NGS Symposium will bring together the community of current and future users of next generation sequencing technology in Vienna, Austria and beyond, to discuss new developments.
Organizers
Christoph Bock, Coordinator of the Biomedical Sequencing Facility (BSF) of CeMM and the Medical University of Vienna, http://www.biomedical-sequencing.at.
Andreas Sommer, Coordinator of the NGS unit at the Vienna Biocenter Core Facilities (VBCF), http://www.vbcf.ac.at/facilities/next-generation-sequencing/.
We have reached full capacity, registration is closed.
CeMM Level 8, Seminar Room
Bruno Amati
Director, Oncogenes, Chromatin and Cell Cycle Control Unit, European Institute of Oncology, Milano, Italy
"Transcriptional programs and therapeutic targets in MYC-driven tumors"
Host: Giulio Superti-Furga
CeMM Level 8, Seminar Room
Andreas Pichlmair
Immunopathology of Virus Infections, Institute of Virology, Technical University of Munich, Germany
"Mass spectrometry based survey of infected cells and antiviral responses – Inhibitome vs Defendome"
Host: Giulio Superti-Furga
Biosketch:
Andreas Pichlmair’s main focus are interactions between viruses and their hosts, and the relevance of these interactions for viral pathogenicity. After studying veterinary medicine in Vienna, Austria, he did his doctor of veterinary medicine (DVM) degree in the Department of Virology (Prof. Otto Haller), University of Freiburg, Germany, working on the antiviral properties of the orthomyxovirus resistance gene (Mx A) in an in vivo orthomyxovirus infection model. This was followed by a PHD in Prof. Caetano Reis e Sousa’s Laboratory (Cancer Research UK) identifying RIG-I as sensor for viral triphosphorylated RNA. During his Post-Doc with Giulio Superti-Furga at CeMM (Center for Molecular Medicine of the Austrian Academy of Sciences) he studied protein complexes between cellular proteins with viral RNA and viral proteins, which allowed a view on strategies of viral perturbations of the innate immune system and identification of cellular proteins specifically binding to viral RNAs. Since Nov. 2011 Andreas is heading his own research group. First as a Max-Planck research group funded by the Max-Planck society and the ERC, and since 2017 as Associate Professor funded by the German Center for Infection Research (DZIF) at the TUM.
December 10th, 2018, 6.00 pm
CeMM Lecture Hall, Level 8
Prof. Wolfgang Lutz
Founding Director, Wittgenstein Centre for Demography and Global Human Capital (IIASA, VID/ÖAW, WU),
Leader, World Population Program (IIASA),
Director, Vienna Institute of Demography (VID), Austrian Academy of Sciences,
Professor of Applied Statistics and Director of Research Institute on Human Capital and Development (WU - Vienna University of Economics and Business)
Host: Prof. Giulio Superti-Furga, Ph.D., CeMM
CeMM Level 8, Seminar Room
Franziska Michor
Dana-Farber Cancer Institute, Department of Biostatistics and Computational Biology, Boston, USA
"DNA methylation profiling for non-invasive early cancer diagnosis"
Host: Giulio Superti-Furga
Biosketch:
Dr. Michor is a Professor of Computational Biology in the Department of Biostatistics and Computational Biology at the Dana-Farber Cancer Institute, in the Department of Biostatistics at the Harvard T.H. Chan School of Public Health, and in the Department of Stem Cell and Regenerative Biology at Harvard University. Dr. Michor obtained her undergraduate training in mathematics and molecular biology from the University of Vienna, Austria, and her PhD from the Department of Organismic and Evolutionary Biology at Harvard University. Afterwards, she was awarded a fellowship from the Harvard Society of Fellows. From 2007 until 2010, she was an Assistant Professor in the Computational Biology Program at Memorial Sloan-Kettering Cancer Center. Dr. Michor is the director of the Dana-Farber Cancer Institute Physical Sciences-Oncology Center and the Center for Cancer Evolution. She has been the recipient of the Theodosius Dobzhansky Prize of the Society for the Study of Evolution, the Alice Hamilton Award, the Vilcek Prize for Creative Promise in Biomedical Science, the 36th Annual AACR Award for Outstanding Achievement in Cancer Research, and others. Dr. Michor's laboratory investigates the evolutionary dynamics of cancer initiation, progression, response to therapy, and emergence of resistance.
CeMM Level 8, Seminar Room
Nicolas Thomä
FMI Basel, Switzerland
"The CRL4 ubiquitin ligase: at the intersection of genome stability and drug discovery"
Host: Georg Winter
